Vanguard Group
ACHV icon

Vanguard Group’s Achieve Life Sciences ACHV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.86M Buy
2,149,877
+432,863
+25% +$978K ﹤0.01% 3227
2025
Q1
$4.58M Sell
1,717,014
-32,777
-2% -$87.5K ﹤0.01% 3209
2024
Q4
$6.16M Sell
1,749,791
-190,597
-10% -$671K ﹤0.01% 3179
2024
Q3
$9.2M Buy
1,940,388
+434,657
+29% +$2.06M ﹤0.01% 3000
2024
Q2
$7.08M Buy
1,505,731
+557,290
+59% +$2.62M ﹤0.01% 3094
2024
Q1
$4.31M Buy
948,441
+342,731
+57% +$1.56M ﹤0.01% 3352
2023
Q4
$2.5M Buy
605,710
+11,757
+2% +$48.4K ﹤0.01% 3525
2023
Q3
$2.55M Buy
593,953
+16,160
+3% +$69.5K ﹤0.01% 3506
2023
Q2
$3M Buy
577,793
+158,409
+38% +$822K ﹤0.01% 3521
2023
Q1
$2.85M Buy
419,384
+79,146
+23% +$538K ﹤0.01% 3550
2022
Q4
$834K Sell
340,238
-8,075
-2% -$19.8K ﹤0.01% 3968
2022
Q3
$1.15M Sell
348,313
-2,307
-0.7% -$7.61K ﹤0.01% 3959
2022
Q2
$1.71M Buy
350,620
+7,715
+2% +$37.6K ﹤0.01% 3873
2022
Q1
$2.6M Sell
342,905
-2,870
-0.8% -$21.7K ﹤0.01% 3853
2021
Q4
$2.69M Buy
345,775
+76,918
+29% +$598K ﹤0.01% 3927
2021
Q3
$2.29M Buy
268,857
+19,975
+8% +$170K ﹤0.01% 4019
2021
Q2
$2.24M Sell
248,882
-47,067
-16% -$423K ﹤0.01% 3940
2021
Q1
$3.43M Buy
295,949
+268,741
+988% +$3.11M ﹤0.01% 3705
2020
Q4
$220K Buy
27,208
+9,402
+53% +$76K ﹤0.01% 4076
2020
Q3
$149K Sell
17,806
-338,325
-95% -$2.83M ﹤0.01% 3981
2020
Q2
$141K Hold
356,131
﹤0.01% 3958
2020
Q1
$116K Buy
356,131
+327,021
+1,123% +$107K ﹤0.01% 3923
2019
Q4
$15K Sell
29,110
-163,526
-85% -$84.3K ﹤0.01% 4101
2019
Q3
$328K Sell
192,636
-81,883
-30% -$139K ﹤0.01% 3882
2019
Q2
$530K Buy
274,519
+165,667
+152% +$320K ﹤0.01% 3814
2019
Q1
$352K Buy
108,852
+73,284
+206% +$237K ﹤0.01% 3830
2018
Q4
$43K Buy
35,568
+100
+0.3% +$121 ﹤0.01% 4082
2018
Q3
$112K Buy
35,468
+22,299
+169% +$70.4K ﹤0.01% 4060
2018
Q2
$50K Sell
13,169
-128,366
-91% -$487K ﹤0.01% 4098
2018
Q1
$180K Buy
141,535
+6,061
+4% +$7.71K ﹤0.01% 3966
2017
Q4
$183K Buy
135,474
+36,558
+37% +$49.4K ﹤0.01% 3946
2017
Q3
$201K Sell
98,916
-489,652
-83% -$995K ﹤0.01% 3921
2017
Q2
$212K Sell
588,568
-85,510
-13% -$30.8K ﹤0.01% 3891
2017
Q1
$297K Buy
674,078
+2,800
+0.4% +$1.23K ﹤0.01% 3839
2016
Q4
$336K Sell
671,278
-99,682
-13% -$49.9K ﹤0.01% 3806
2016
Q3
$391K Sell
770,960
-69,784
-8% -$35.4K ﹤0.01% 3804
2016
Q2
$841K Hold
840,744
﹤0.01% 3651
2016
Q1
$575K Buy
840,744
+80,466
+11% +$55K ﹤0.01% 3750
2015
Q4
$920K Buy
760,278
+1,133
+0.1% +$1.37K ﹤0.01% 3653
2015
Q3
$1.69M Buy
759,145
+265,676
+54% +$592K ﹤0.01% 3450
2015
Q2
$1.15M Buy
493,469
+27,971
+6% +$65.1K ﹤0.01% 3623
2015
Q1
$1M Buy
465,498
+46,141
+11% +$99.2K ﹤0.01% 3632
2014
Q4
$960K Buy
419,357
+14,772
+4% +$33.8K ﹤0.01% 3539
2014
Q3
$1.08M Buy
404,585
+64,192
+19% +$171K ﹤0.01% 3482
2014
Q2
$1.27M Buy
340,393
+14,996
+5% +$56K ﹤0.01% 3422
2014
Q1
$3.83M Buy
325,397
+112,405
+53% +$1.32M ﹤0.01% 2958
2013
Q4
$1.78M Sell
212,992
-62,156
-23% -$518K ﹤0.01% 3234
2013
Q3
$2.55M Sell
275,148
-552
-0.2% -$5.12K ﹤0.01% 3041
2013
Q2
$2.7M Buy
+275,700
New +$2.7M ﹤0.01% 2961